Ranbaxy Laboratories obtains US FDA approval to market fenofibrate capsules EP News Bureau Nov 5, 2014 Fenofibrate capsules are indicated for primary hypercholesterolemia and mixed dyslipidemia. In addition, it is indicated for…
